“China National Biotech Group” for pharmaceuticals has become the first company in China to submit an application for approval of its vaccine against the emerging corona virus (Covid-19), to be released to the public there, according to what the director of the parent company, “Sinopharma”, told Xinhua today. Wednesday.
Although no data on the effectiveness of the vaccine have been released yet, it has already been administered to about one million people as part of an urgent vaccination program, according to Sinopharma last week.
There were no reports of severe side effects, and only mild symptoms appeared on some of the participants, according to the report.
Chinese official media have reported for weeks about programs to administer the vaccine to certain groups of the population, such as Chinese military personnel, health workers, diplomats and employees of state companies.
Follow our latest local and sports news, and the latest political and economic developments via Google news